{"slideshow_credits": null, "snippet": "The company said hospitals would be eligible for a discount of 10 percent to 40 percent on the heart drugs Nitropress and Isuprel.", "abstract": "Valeant Pharmaceuticals International unveils new plan that simplifies and expands its previous discount program for two heart medications, Nitropress and Isuprel; announcement follows Congressional hearings on complaints firm failed in its 2015 pledge to give price cuts to hospitals and large purchasers.", "section_name": "Business Day", "print_page": "3", "document_type": "article", "byline": {"person": [{"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 1, "organization": ""}], "original": "By KATIE THOMAS"}, "web_url": "http://www.nytimes.com/2016/05/17/business/valeant-pharmaceuticals-expands-drug-discount-offer-after-criticism.html", "lead_paragraph": "The company said hospitals would be eligible for a discount of 10 percent to 40 percent on the heart drugs Nitropress and Isuprel.", "headline": {"main": "Valeant Pharmaceuticals Expands Drug Discount Offer After Criticism", "print_headline": "Valeant Expands Drug Discount Offer After Criticism"}, "_id": "5739e16738f0d83bc1f16560", "word_count": "835", "multimedia": [{"height": 126, "url": "images/2016/05/17/business/17valeant/17valeant-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2016/05/17/business/17valeant/17valeant-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 393, "url": "images/2016/05/17/business/17valeant/17valeant-articleLarge.jpg", "legacy": {"xlarge": "images/2016/05/17/business/17valeant/17valeant-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "393"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2016/05/17/business/17valeant/17valeant-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/05/17/business/17valeant/17valeant-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2016-05-17T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "2"}], "blog": [], "subsection_name": null, "type_of_material": "News"}